Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a newer version of the page content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows revision v3.6.5, indicating a newer revision of the study details page was loaded. No substantive content changes are indicated by this revision.SummaryDifference0.1%

- Check47 days agoChange DetectedAn updated revision tag shows the page moving from v3.6.3 to v3.6.4, indicating a minor update to the page template or metadata rather than substantive content changes.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.6.3 is now displayed, indicating a small software version update to the site's interface. This change does not affect study details or other user-facing information.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a newer version of the study documents on ClinicalTrials.gov.SummaryDifference0.1%

- Check89 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants, signaling that enrollment has completed. Added navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and minor formatting changes to the Intervention/Treatment label, along with a revision tag update from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.